Reuters: Health
Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss drugmaker said on Thursday.
Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial
Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial
Reuters: Health
Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss drugmaker said on Thursday.
Reuters: Health
Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss drugmaker said on Thursday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment